Phase 2 Biphenotypic Acute Leukemia Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Allo HSCT Using RIC and PTCy for Hematological Diseases
Acute Myelogenous LeukemiaMyelodysplastic SyndromesLeukemia, Myeloid+15 more
Masonic Cancer Center, University of Minnesota56 enrolled1 locationNCT05805605
Recruiting
Phase 2Phase 3
Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis
Acute Lymphoblastic LeukemiaMyelodysplastic SyndromeBiphenotypic Acute Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology50 enrolled1 locationNCT06756152
Recruiting
Phase 2
Vitamin A and D Supplementation in Allogeneic HCT
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+4 more
St. Petersburg State Pavlov Medical University220 enrolled1 locationNCT06508099
Recruiting
Phase 2
BeFluBu vs FluBuRux Conditioning in Haploidentical HCT
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndromes+3 more
St. Petersburg State Pavlov Medical University220 enrolled1 locationNCT06477549